Golden Triangle
GSK reveals plans for £400m R&D facility expansion in England
GSK has formally started the process of seeking a development partner for the expansion plans
eureKARE to use $60m financing to bolster next-generation European biotech companies
New company is focused on financing biotech companies and new ventures in Europe working on the microbiome and synthetic biology
UK biotech Synairgen treats first patient in phase 3 COVID-19 trial
SNG001 delivers an inhaled formulation of Interferon-beta-1a directly to the lungs
Chancellor’s ‘coronavirus budget’ also pledges big R&D gains
Includes measures to help businesses disrupted by the pandemic
ReNeuron set for recovery after Woodford stake sale
Edison analyst says sale should help shares to stabilise
UK biotech funding falls 40% between 2018 and 2019
Drop attributed to global uncertainty and Neil Woodford scandal
UK immunology biotech MiroBio launches with $34m fundraising
Will develop therapeutic antibodies for autoimmune diseases
European biotech: a new generation of leaders emerges
Three companies that are on the rise in biotech
Building Europe’s next breakthrough biotechs
Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK
Novartis and J&J back latest €400m Medicxi biopharma fund
Growing appetite from European investors to back early-stage biotechs
Illumina sets up first ex-US accelerator site in Cambridge
Boost for UK's golden triangle biotech region
Gilead strikes $5.1bn deal to bolster ties with Galapagos
Big boost for Belgian biotech, without a buy-out